Abstract
References
1.
Stewart
PM
Stears
A
Tomlinson
JW
Brown
MJ
. Regulation – the real threat to clinical research . BMJ 2008 ; 337 :a1732 .
2.
Griffin
GE
Brown
M
Gilmore
I
Wright
N
Douglas N plus 109 members of the Assoc Clin Profs of Med
. UK research trials are on verge of extinction (letter) . The Times 14 Jan 09, p4 .
3.
Wisely
J
. NRES: challenges and opportunities . Res Ethics Rev 2009 ; 5 (1 ):14 .
4.Bureaucracy busting: governance, advice and ethics systems . Best research for best health implementation plan 4.1 . National Institute for Health Research , updated January 2009 . Available at http://www.nihr.ac.uk/files/Forms/AllItems.aspx?RootFolder=http%3a%2f%2fwww%2enihr%2eac%2euk%2ffiles%2fpdfs&FolderCTID=0times01200045AC23D4C2A24E4FBA0A653046080A34.
5.
Schipper
I
Weyzig
F
. Ethics for drug testing in low and middle income countries: considerations for European market authorisation . Centre for research on multinational corporations (SOMO) , February 2008 . Available at http://somo.nl/publicationsen/Publication-2472/?searchterm=ethics%20for%20drug%20testing.